Effects of odanacatib on bone matrix mineralization in rhesus monkeys are similar to those of alendronate.

Misof, Barbara M; Roschger, Paul; Chen, Charles; Pickarski, Maureen; Messmer, Phaedra; Klaushofer, Klaus; Duong, Le T

Misof, Barbara M; Roschger, Paul; Chen, Charles; Pickarski, Maureen; Messmer, Phaedra; Klaushofer, Klaus; Duong, Le T.

Afiliación

Misof BM; Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria.
Roschger P; Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria.
Chen C; Merck Research Laboratories, West Point, PA 19486, USA.
Pickarski M; Merck Research Laboratories, West Point, PA 19486, USA.
Messmer P; Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria.
Klaushofer K; Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria.
Duong LT; Merck Research Laboratories, West Point, PA 19486, USA.

Bone Rep ; 5: 62-69, 2016 Dec.

Article en En | MEDLINE | ID: mdl-28326348

Palabras clave

Alendronate; Bone quality; Cathepsin K inhibitor; Odanacatib; Osteoporosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Bone Rep Año: 2016 Tipo del documento: Article País de afiliación: Austria

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google